Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      Traders News Source Senior Editor, Mark Roberts Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier
      Health

      Traders News Source Senior Editor, Mark Roberts Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier

      August 10, 2022
      Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2022 and Reiterates Key Anticipated Near-Term Milestones
      Health

      Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2022 and Reiterates Key Anticipated Near-Term Milestones

      August 10, 2022
      Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
      Health

      Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering

      August 10, 2022
      Welltower Issues Business Update
      Health

      Welltower Issues Business Update

      August 10, 2022
      Emergent BioSolutions Reports Financial Results for Second Quarter 2022
      Health

      Emergent BioSolutions Reports Financial Results for Second Quarter 2022

      August 9, 2022
      Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination
      Health

      Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination

      August 9, 2022
      Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 “EVOGUARD” Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women
      Health

      Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 “EVOGUARD” Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women

      August 9, 2022
      Evofem Biosciences Unveils New Educational Birth Control Chart to Assist Providers in Patient Contraceptive Counseling
      Health

      Evofem Biosciences Unveils New Educational Birth Control Chart to Assist Providers in Patient Contraceptive Counseling

      August 9, 2022
      Humanigen Implements Strategic Realignment of Pipeline and Resources to Achieve Key Clinical Milestones
      Health

      Humanigen Implements Strategic Realignment of Pipeline and Resources to Achieve Key Clinical Milestones

      August 9, 2022
      GeoVax to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate Update
      Health

      GeoVax to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate Update

      August 9, 2022
      « 1 … 228 229 230 231 232 … 240 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026